Perceived Spasticity and Treatment Satisfaction Among Stroke Survivors Over the Course of a Complete Treatment Cycle With Botulinum Neurotoxin A (BoNT-A): an Ethnographic Study
Latest Information Update: 10 Jun 2021
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- Acronyms REBOT
- Sponsors Ipsen
Most Recent Events
- 22 Apr 2021 Results assessing changes in symptom burden and their effects/interference on patient functioning and quality of life throughout the duration of a botulinum toxin type A (BoNT-A) treatment cycle, presented at the 73rd Annual Meeting of the American Academy of Neurology.
- 16 Sep 2020 Trial design presented at the 24th International Congress of Parkinson's Disease and Movement Disorders.
- 29 May 2020 Status changed from active, no longer recruiting to completed.